SYDNEY (Reuters) – Australia’s medical regulator said on Tuesday it had granted provisional approval for the COVID-19 vaccine developed by AstraZeneca, making it the second vaccine to get regulatory approval in Australia.
The regulator last month approved the Pfizer-BioNTech COVID-19 vaccine for use and inoculations for its 25 million population will begin from Feb. 22.
(Reporting by Renju Jose; Editing by Jacqueline Wong)
